Published in J Dtsch Dermatol Ges on September 01, 2003
Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat Biotechnol (2006) 4.71
Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood (2005) 2.55
New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol (2009) 2.28
Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol (2009) 2.02
Managing comorbid disease in patients with psoriasis. BMJ (2010) 1.89
KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment. J Natl Cancer Inst (2008) 1.72
Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J Invest Dermatol (2004) 1.70
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood (2010) 1.67
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol (2007) 1.59
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial. Acta Oncol (2006) 1.48
Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol (2010) 1.43
[Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (PhotoDyn 501): practical experiences in problem-patients with actinic keratoses and basal cell carcinomas]. J Dtsch Dermatol Ges (2004) 1.38
An all-printed ferroelectric active matrix sensor network based on only five functional materials forming a touchless control interface. Adv Mater (2011) 1.34
Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J (2012) 1.31
Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology (2002) 1.31
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst (2003) 1.25
Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. J Biol Chem (2011) 1.19
A role for caspase-1 in heart failure. Circ Res (2007) 1.13
8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol (2010) 1.13
Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J (2012) 1.10
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol (2005) 1.10
The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr Med Chem (2007) 1.09
P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther Targets (2007) 1.06
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol (2006) 1.06
Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol (2010) 1.04
Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol (2010) 0.99
Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One (2013) 0.99
Update in retinoid therapy of acne. Dermatol Ther (2006) 0.98
The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania. Arch Dermatol (2005) 0.97
Reliability of diagnosis of melanoma in situ. Lancet (2002) 0.96
Treatment of scalp angiosarcoma by controlled perfusion of A. carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa. J Am Acad Dermatol (2005) 0.96
NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways. J Invest Dermatol (2009) 0.95
Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol (2004) 0.95
Dendritic epidermal T cells (DETC) are diminished in integrin alphaE(CD103)-deficient mice. J Invest Dermatol (2002) 0.94
[Current situation of dermatologic surgery in Germany]. J Dtsch Dermatol Ges (2006) 0.94
Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity. Proc Natl Acad Sci U S A (2013) 0.94
Successful Nd:YAG laser therapy for hair removal in the oral cavity after plastic reconstruction using hairy donor sites. Dermatology (2013) 0.93
Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro. Mol Immunol (2004) 0.93
Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. Am J Pathol (2011) 0.92
Melanoma arising in segmental nevus spilus: detection by sequential digital dermatoscopy. J Am Acad Dermatol (2009) 0.92
Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol (2008) 0.91
The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases. Front Biosci (2008) 0.90
Integrin alpha E(CD103)beta 7 influences cellular shape and motility in a ligand-dependent fashion. Blood (2008) 0.90
Comparative in situ topoproteome analysis reveals differences in patch test-induced eczema: cytotoxicity-dominated nickel versus pleiotrope pollen reaction. Exp Dermatol (2009) 0.90
Tumor necrosis factor antagonists in the therapy of psoriasis. Clin Dermatol (2008) 0.90
Inhibition of platelet GPIb alpha and promotion of melanoma metastasis. J Invest Dermatol (2009) 0.89
Cowpox infection transmitted from a domestic cat. J Dtsch Dermatol Ges (2008) 0.89
The dark side of beauty: acne fulminans induced by anabolic steroids in a male bodybuilder. Arch Dermatol (2012) 0.89
Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. J Am Acad Dermatol (2011) 0.89
Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair. Exp Dermatol (2012) 0.88
Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders? Trends Pharmacol Sci (2003) 0.88
Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription. J Invest Dermatol (2013) 0.88
Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis. J Invest Dermatol (2007) 0.88
Successful treatment of a large hemangioma with propranolol. J Dtsch Dermatol Ges (2009) 0.87
Animal models of psoriasis. Clin Dermatol (2007) 0.87
Profiling lymphocyte subpopulations in peripheral blood under efalizumab treatment of psoriasis by multi epitope ligand cartography (MELC) robot microscopy. Eur J Dermatol (2007) 0.87
Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein Ibα. ACS Nano (2013) 0.87
Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin. Immunology (2009) 0.87
PECAM-1 polymorphism affects monocyte adhesion to endothelial cells. Transplantation (2008) 0.86
Successful treatment of severe keratosis pilaris rubra with a 595-nm pulsed dye laser. Dermatol Surg (2009) 0.86
A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes. J Immunol Methods (2004) 0.85
Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM). J Invest Dermatol (2005) 0.85
Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol (2002) 0.85
Development of segmental superficial actinic porokeratosis during immunosuppressive therapy for pemphigus vulgaris. Acta Derm Venereol (2010) 0.85
Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach? Exp Dermatol (2007) 0.85
Recommendations for detection of individual risk for comorbidities in patients with psoriasis. Arch Dermatol Res (2013) 0.85
Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. Cutis (2004) 0.85
Beliefs, perceptions, and treatment modalities of acne among schoolchildren in Lithuania: a cross-sectional study. Int J Dermatol (2015) 0.84
Complete remission of alopecia areata under treatment of chronic hand eczema with alitretinoin. Eur J Dermatol (2013) 0.84
Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition. Exp Dermatol (2011) 0.84
Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes. Exp Dermatol (2013) 0.84
Cutaneous side effects of inhibition of VEGF signal transduction. J Dtsch Dermatol Ges (2009) 0.84
Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression. Exp Dermatol (2011) 0.84
Impaired induction of adhesion molecule expression in immortalized endothelial cells leads to functional defects in dynamic interactions with lymphocytes. J Invest Dermatol (2007) 0.84
Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil. J Dtsch Dermatol Ges (2009) 0.84
In-situ-topoproteome analysis of cutaneous lymphomas: perspectives of assistance for dermatohistologic diagnostics by Multi Epitope Ligand Cartography (MELC). J Dtsch Dermatol Ges (2008) 0.84
Seven-point checklist for dermatoscopy: performance during 10 years of prospective surveillance of patients at increased melanoma risk. J Am Acad Dermatol (2010) 0.84
Molecular biology of basal and squamous cell carcinomas. Adv Exp Med Biol (2014) 0.83
Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions. Exp Dermatol (2011) 0.83
Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations. Exp Dermatol (2012) 0.83
Therapy of psoriasis in childhood and adolescence - a German expert consensus. J Dtsch Dermatol Ges (2011) 0.83
Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet (2003) 0.83
[S2k-guideline for therapy of acne]. J Dtsch Dermatol Ges (2010) 0.83
PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions. J Invest Dermatol (2008) 0.82
Bacteriological pathogen spectrum of chronic leg ulcers: Results of a multicenter trial in dermatologic wound care centers differentiated by regions. J Dtsch Dermatol Ges (2013) 0.82
Perioral dermatitis. J Dtsch Dermatol Ges (2010) 0.82
Premonitory epidermolysis bullosa acquisita mimicking eyelid dermatitis: successful treatment with rituximab and protein A immunoapheresis. Am J Clin Dermatol (2010) 0.82
Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation. J Invest Dermatol (2006) 0.82
Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions. J Clin Invest (2010) 0.81
Multifocal capillary malformations due to RASA1 mutation misdiagnosed as cutaneous mastocytosis. Arch Dermatol (2012) 0.81
Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes. Cancer Immunol Immunother (2007) 0.81
Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. Haematologica (2007) 0.81
No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study. Arch Dermatol Res (2012) 0.81
Varicella outbreak in Indian students in Magdeburg with detection of the African-Indian VZV clade 5. J Dtsch Dermatol Ges (2010) 0.81
High incidence of naevi-associated BRAF wild-type melanoma and dysplastic naevi under treatment with the class I BRAF inhibitor vemurafenib. Acta Derm Venereol (2014) 0.80
Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch. Exp Dermatol (2008) 0.80